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Mentor: Lee Ratner
Little is known about the development of CCR5-antagonist resistant HIV-1 in vivo. We 
analyzed one subject who was found to have both R5 and X4-using virus at virological 
failure from a phase II clinical trial of Vicriviroc (VCV). The presence of multiple viral 
tropisms indicates the multiple mechanisms of drug evasion. Our findings may describe 
the early transition into drug resistance. Studies with VCV based susceptibility assays 
show that there is a phenotypic difference between the R5 viral populations from week 0 
(baseline) and 8 (virological failure). Genotypic analysis of the R5-population overtime 
suggest that the V1 region may facilitate more effective use of CCR5 or CD4 and may 
also contribute to VCV-susceptibility.
